本页面由Tiger Trade Technology Pte. Ltd.提供服务

CervoMed

8.69
-0.3700-4.08%
盘后8.930.2400+2.76%19:26 EST
成交量:5.68万
成交额:50.96万
市值:8,040.61万
市盈率:-3.02
高:9.22
开:9.21
低:8.64
收:9.06
52周最高:16.94
52周最低:1.80
股本:925.27万
流通股本:493.43万
量比:0.68
换手率:1.15%
股息:- -
股息率:- -
每股收益(TTM):-2.8732
每股收益(LYR):-2.0179
净资产收益率:-71.42%
总资产收益率:-42.78%
市净率:3.09
市盈率(LYR):-4.31

数据加载中...

公司资料

公司名字:
CervoMed
交易所:
NASDAQ
成立时间:
2010
员工人数:
15
公司地址:
20 Park Plaza,Suite 424,Boston,Massachusetts,United States
邮编:
02116
电话:
传真:
- -
简介:
CervoMed Inc.于2015年6月18日在特拉华州注册成立。该公司是一家临床阶段的生物技术公司,专注于开发与年龄相关的神经系统疾病的治疗方法。

董事

名称
职位
John Alam
Director, President and Chief Executive Officer
Robert J. Cobuzzi, Jr.
Director, Chief Operating Officer
David Quigley
Director
Frank Zavrl
Director
Jane H. Hollingsworth
Director
Jeff Poulton
Director
Joshua S. Boger
Director
Marwan Sabbagh
Director
Sylvie Gregoire
Director

股东

名称
职位
John Alam
Director, President and Chief Executive Officer
Robert J. Cobuzzi, Jr.
Director, Chief Operating Officer
William R. Elder
Chief Financial Officer, General Counsel and Corporate Secretary
Kelly Blackburn
Executive Vice President, Clinical Development
Mark De Rosch
Executive Vice President, Regulatory and Government Affairs and Program Management